Covered.
Covered. / CGM / New York
New York · Medicare DME Coverage

Does New York Medicaid Cover a CGM?

Last verified May 1, 2026 · 3 sources cited

Yes — Medicare Part B covers a continuous glucose monitor (CGM) when you have diabetes and meet documented monitoring criteria. As of 2023, you no longer need to be on insulin if you have a documented history of problematic hypoglycemia.

Who qualifies

  • You have a diagnosis of diabetes (Type 1 or Type 2).
  • Your doctor has prescribed the CGM and documents the medical need.
  • You either use insulin OR have a documented history of problematic hypoglycemia.
  • You or your caregiver are trained to use the device and act on its readings.

Qualifying conditions

  • Type 1 diabetes
  • Type 2 diabetes on insulin
  • Type 2 diabetes with documented problematic hypoglycemia (CMS expanded criteria, effective April 2023)

What it costs

2026 Part B deductible
$240
Your coinsurance
20%
  • After meeting the Part B deductible, Medicare pays 80%; you pay the remaining 20% — unless you have a Medigap plan that covers it.
  • Most Medicare Advantage plans cover CGM at parity, but copay structures vary.
  • Supplies (sensors, transmitters) ship as a recurring DME benefit — usually monthly or quarterly.

Check if you qualify

Step 1 of 2

Takes about 60 seconds. We'll show you what your plan covers and connect you with a supplier if you qualify for CGM.

Prior authorization timeline

Typically 5–10 business days once your doctor submits the order and clinical documentation.

Frequently asked

Does Medicare cover a CGM if I'm not on insulin?

Yes, as of April 2023. CMS expanded coverage to include people with Type 2 diabetes who have a documented history of problematic hypoglycemia, even without insulin use. Your doctor must document at least two qualifying hypoglycemic events.

Which CGMs does Medicare cover?

Medicare covers therapeutic CGMs that meet FDA non-adjunctive use criteria — currently Dexcom G6/G7, FreeStyle Libre 2/3, and Eversense. Stelo and other over-the-counter CGMs are not currently Medicare-covered as of 2026.

How much does a CGM cost with Medicare?

After the 2026 Part B deductible ($240), you pay 20% coinsurance on the Medicare-approved amount. Out-of-pocket monthly cost typically runs $40–$80 depending on the device and your supplemental coverage.

Can I switch from FreeStyle Libre to Dexcom on Medicare?

Yes. Your doctor writes a new prescription for the device you want, and your DME supplier processes the switch. There is no waiting period, but you cannot bill both devices in the same supply month.

Does Medicaid cover CGM?

It varies by state. Many states cover CGM under Medicaid for Type 1 and insulin-dependent Type 2; non-insulin coverage is expanding but inconsistent. See our state-specific pages for current rules.

Sources

New York Medicaid coverage

Covered

NY Medicaid covers CGMs under the NYRx Preferred Diabetic Supply Program (PDSP) — a pharmacy benefit. As of June 3, 2024, DMEPOS providers can no longer bill CGMs; they must be dispensed by enrolled pharmacies.

Timeline
24 hours urgent / 72 hours standard pharmacy PA

Who qualifies in New York

  • Diabetes diagnosis with insulin therapy OR history of problematic hypoglycemia / hypoglycemia unawareness
  • Prescription from a Medicaid-enrolled provider
  • Device must appear on the NYRx PDSP Preferred Supply List

Supplier requirements

Must be filled at a pharmacy enrolled in NYRx (the FFS pharmacy program). DME providers cannot bill CGMs as of 6/3/2024.

Managed care

Pharmacy benefit (including CGMs) is CARVED OUT of NY Medicaid Managed Care to NYRx FFS for all members since April 2023. MCO does not adjudicate.

Common gotchas (most reference sites miss these)

  • DMEPOS-to-pharmacy transition (June 2024) is the #1 cause of denials — old DME suppliers still try to bill and get rejected
  • Existing PAs from before the carve-out are honored only through their original expiration date
  • PDSP Preferred List drives coverage — non-preferred CGMs require step therapy or denial

Sources for New York